Erciyas Celik Boru Sanayi AS

Erciyas Celik Boru Sanayi AS has a price-to-book ratio of 1.31 and a debt-to-equity ratio of 1.58, indicating a leveraged capital structure with limited liquidity, as evidenced by negative net cash after subtracting total debt. The company's current ratio of 1.65 suggests it can cover short-term liabilities, but its operating cash flow of -746.06 million TRY and free cash flow of -139.68 million TRY highlight ongoing cash flow challenges. Profitability metrics are weak, with a return on equity of -11.42% and a return on assets of -2.81%, both significantly below the industry median for Iron & Steel producers. The company reported a net loss of 405.84 million TRY and an operating loss of 227.94 million TRY, reflecting a challenging operating environment and cost pressures. The company's revenue is concentrated in Turkey, with disclosed exports to over 20 countries, but no specific revenue by region is provided. This lack of geographic diversification may expose the company to regional economic and political risks, particularly in Turkey, where inflation and currency volatility are ongoing concerns. Growth appears constrained, with no clear revenue growth trajectory in the outlook. The company's capital expenditure of -47.28 million TRY suggests ongoing investment, but the negative operating and net income indicate that these investments have not yet translated into profitability. The absence of positive revenue deltas in the outlook further signals a period of stagnation or contraction. Risk factors include liquidity constraints, with a medium liquidity risk score and a negative net cash position. The company's debt load and negative cash flows increase the risk of financial distress. Dilution risk is currently low, but the company's negative net income and cash flow could necessitate future equity raises, which would dilute existing shareholders. Recent events include the company's continued operations in Duzce and Mersin, with exports to a broad range of countries. No recent filings or transcripts were provided in the input data, so no specific recent developments can be cited.